-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Karuna Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q4 2023.
- Karuna Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 37M shares, a 16.9% increase year-over-year.
- Karuna Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 37M shares, a 16.9% increase from 2022.
- Karuna Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 31.6M shares, a 8.55% increase from 2021.
- Karuna Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 29.1M shares, a 10.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)